Supplement use during an intergroup clinical trial for breast cancer (S0221)

Supplement use during an intergroup clinical trial for breast cancer (S0221)

The use of supplements during chemotherapy is controversial, partly due to the potential effect of antioxidants on reduced efficacy of chemotherapy-related cytotoxicity. We examined supplement use among breast cancer patients registered to a clinical trial (SWOG 0221) before diagnosis and during tre...

Full description

Bibliographic Details
Main Authors: Zirpoli, Gary R., Brennan, Patrick M., Hong, Chi-Chen, McCann, Susan E., Ciupak, Gregory, Davis, Warren, Unger, Joseph M., Thomas Budd, G., Hershman, Dawn L., Moore, Halle C.F., Stewart, James, Isaacs, Claudine, Hobday, Timothy, Salim, Muhammad, Hortobagyi, Gabriel N., Gralow, Julie R., Albain, Kathy S., Ambrosone, Christine B.
Format: Online
Language:English
Published: Springer US 2013
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3552360/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3552360/

Similar Items